CClinicalTrials.gg
CompletedNCT01659840TMDUpdated Aug 8, 2012

Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders

An interventional study of Red laser and Infrared laser in Temporomandibular Disorders, sponsored by Federal University of São Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-08-08.

Sponsored by Federal University of São Paulo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The study hypothesis was that the red (600nm) and infrared (800nm) laser therapy have the same efficacy in relieving pain and improving the quality of life of TMD patients

Read the detailed description

The aim of the present study was to evaluate and compare the efficacy of red (600nm) and infrared (800nm) laser therapy in relieving pain and improving the quality of life of TMD patients.

02

Conditions studied

  • Temporomandibular Disorders

Keywords

  • laser,
  • quality of life,
  • orofacial pain
03

In context

Temporomandibular Joint Disorders

609 studies on the registry are indexed under Temporomandibular Joint Disorders; 160 are open to participants now.

This study's enrollment of 116 is above the median of 46 across 434 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • systemic health;
  • Temporomandibular Disorder diagnosed by the Research Diagnostic Criteria for Temporomandibular Disorders questionnaire (RDC);
  • pain score ≥ 5 on palpation according to a visual and numerical scale (VNS)

Exclusion criteria

Exclusion Criteria:

  • participants who made frequent use of analgesics, NSAIDs and antidepressants;
  • patients with previously undergone TMD treatment, or suffered facial trauma
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
116 participants (actual)

Study arms

  • Other
    Red laser

    On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

    Radiation: Red laser

  • Other
    Infrared laser

    On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

    Radiation: Infrared laser

Interventions

  • RadiationRed laser

    On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

  • RadiationInfrared laser

    On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

06

What researchers measure

Primary outcomes

  1. pain points of muscle and articulation

    Time frame: 180 days

Secondary outcomes

  1. Quality of life

    Time frame: 180 days

07

Study locations

1 site
  • Periodontics Clinic, Department of Dentistry
    Diamantina, Minas Gerais 39100000, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01659840
Lead sponsor
Federal University of São Paulo
Responsible party
Olga Flecha (Professor, Federal University of São Paulo) — Principal investigator
First posted
Aug 8, 2012
Start date
Sep 2010
Primary completion
Nov 2010
Completion
Nov 2010
Last update
Aug 8, 2012

Study contacts

Olga D Flecha, Professor
principal investigator · Federal University of the Valleys of Jequitinhonha and Mucuri

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion